Hisao Nishimura, Chairman of the Board of Chiral Technologies Inc., wholly owned subsidiary of Daicel Chemical Industries, Ltd., announced that Thomas B. Lewis, Ph.D., President & CEO, would retire in the second quarter of 2006. Chiral Technologies Inc. is a of Japan. Dr. Lewis has held this position since 1992.
Succeeding Dr. Lewis will be Dieter Heckmann, currently President of Chiral Technologies Europe (Strasbourg, France), also a subsidiary of Daicel. Effective with Dr. Lewis' retirement, Mr. Heckmann will hold the position of President and CEO of both Chiral Technologies Inc. and Chiral Technologies Europe. Mr. Heckmann will retain his primary residency in Europe.
Dr. Nishimura indicated that the company is currently conducting an executive search for a Chief Operating Officer of Chiral Technologies Inc., a new position. This person will report to Mr. Heckmann, and manage the day-to-day operations of Chiral Technologies Inc.
Mr. Heckmann has a lengthy career in the industrial chromatography field, having started with Eurochrom/Knauer GmbH of Berlin in 1988, and then moved in the mid-90s to UOP in Heidelberg as Sales Manager SMB-Systems. He joined Chiral Technologies Europe as Director of Marketing in 1997. In 2001 he was promoted to President of Chiral Technologies Europe.
Chiral Technologies Europe Acquires ChromTech Ltd. of U.K.
Chiral Technologies Europe (CTE), a wholly owned subsidiary of DAICEL Chemical Industries, Ltd, announced the acquisition of ChromTech Ltd, of Congleton, U.K. According to the company, the two companies’ combined product lines of enantioselective chromatography columns will provide a powe ... more
Daicel Chemical Industries and Groupe Novasep SAS form a strategic co-operation
Daicel Chemical Industries, Ltd. and Groupe Novasep SAS, announce the formation of a strategic technical co-operation aimed at streamlining the use of chiral chromatography to manufacture late-stage clinical and commercial chiral intermediates and APIs. Under the terms of the agreement, th ... more
Celanese signed contract with Daicel and Polyplastics on Sale of Topas® - COC Business
Celanese Corporation announced that it has signed an agreement to sell its cycloolefine copolymer business (COC) to a joint venture of Daicel Chemical Industries Ltd. and Polyplastics Co., Ltd. As announced earlier, all production facilities and employees will be transferred to this joint v ... more
Chiral Technologies Europe Signs Licensing Agreement with the University of Vienna
Chiral Technologies Europe (CTE) announced that it has entered into an exclusive worldwide licensing agreement with the University of Vienna, Austria. According to the agreement, CTE acquired exclusive manufacturing and marketing rights for novel Cinchona alkaloid-based zwitterion-exchange ... more
Chiral Technologies Europe Signs Distribution Agreement with Hichrom
Chiral Technologies Europe announced it has signed a non-exclusive distribution agreement with Hichrom Ltd. to better serve its customers in the United Kingdom. "We are pleased to formalise our relationship with Hichrom. The technical sales group of Hichrom are well placed to present the b ... more
Chiral Technologies Europe Acquires ChromTech Ltd. of U.K.
Chiral Technologies Europe (CTE), a wholly owned subsidiary of DAICEL Chemical Industries, Ltd, announced the acquisition of ChromTech Ltd, of Congleton, U.K. According to the company, the two companies’ combined product lines of enantioselective chromatography columns will provide a powe ... more
Chiral Technologies Europe SAS
CTE specializes in enantiomeric separation products and services for the pharmaceutical, bio technical and related industries. The company assists customers from initial analysis to production of the finished product. CTE is a wholly owned subsidiary of the Japanese fine chemical producer, ... more
CHIRAL TECHNOLOGIES is the leading supplier of chiral chromatography products and services in North and South America. To maintain our leadership, we continually create new technologies, products, and services, and provide excellent support to meet the rapidly growing needs of our customers ... more
